Drug Profile
Capdoquin
Alternative Names: SYN 1193Latest Information Update: 15 Aug 2007
Price :
$50
*
At a glance
- Originator NAEJA Pharmaceutical; Taiho Pharmaceutical
- Developer Chirologix Pharmaceuticals; NAEJA Pharmaceutical; Taiho Pharmaceutical
- Class Antibacterials; Fluoroquinolones; Small molecules
- Mechanism of Action Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections; Catheter infections
Most Recent Events
- 16 Oct 2001 Preclinical development for Catheter infections in Canada (Unknown route)
- 15 Jun 2001 Discontinued-Preclinical for Bacterial infections in Japan (Unknown route)
- 20 Jul 1998 No-Development-Reported for Bacterial infections in Japan (Unknown route)